N

Neurocrine Biosciences

D
NBIX
USD
-1.26
(-1.0054%)
Market Closed
29,126.00
Volume
5
EPS
-
Div Yield
37.367
P/E
12,527,113,450.94
Market Cap
Today
-1.0054%
1 Week
3.194%
1 Month
10.551%
6 Months
-13.348%
12 Months
6.389%
Year To Date
-5.837%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ACAD
1.42
(8.993%)
USD
T
TEVA
0.075
(0.4307%)
USD
I
INSM
-1.14
(-1.5653%)
USD
S
SAGE
0.385
(6.4815%)
USD
A
ALKS
-0.32
(-1.0925%)
USD
E
ESPR
-0.1
(-4.5351%)
USD
A
ADMS
(%)
USD
S
SRPT
-7.62
(-5.9531%)
USD
A
AVDL
0.41
(2.6797%)
USD

Title:
Neurocrine Biosciences

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Do you need help or have a question?
Contact Us